4-Bromo-1-Chloro-[(4-ethoxyphenyl) methyl benzene
INR 650
In stock
Description
The term “4-Bromo-1-chloro-[(4-ethoxyphenyl) methyl benzene]” refers to an impurity that is a key intermediate used in the synthesis of Dapagliflozin, a medication for type 2 diabetes. It is also known as 4-Bromo-1-chloro-2-(4-ethoxybenzyl)benzene and is used as a reference standard for quality control during the manufacturing of Dapagliflozin.
CAS No: -
461432-23-5
Specifications
| Appearance: | White powder |
|---|---|
| Synonyms:- | 4-Bromo-1-chloro-2-(4-ethoxybenzyl)benzene, 4-(5-Bromo-2-chlorobenzyl)phenyl ethyl ether, 5-Bromo-2-chloro-4′- Impurity ethoxydiphenylmethane, Dapagliflozin Bromo, Benzene, 4-bromo-1-chloro-2-[(4-ethoxyphenyl)methyl]-, (5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)methylene |
| Packing :- | Powder form :- 25 Kg in HEDP bag with 2 liners (5 layer protected bag) |
| Molecular Weight | 325.63 g/mol |
| Purity | A common quality standard for this intermediate is a purity of 99.0% or higher, as measured by High-Performance Liquid Chromatography (HPLC) |
| Application: | As a key intermediate in the synthesis of Dapagliflozin API |